Engaged Patients. Better Trials.
uMotif provides the next generation eCOA/ePRO and engagement platform designed to power clinical, post-marketing and real-world research.
Designed in collaboration with patients to deliver unrivaled engagement-transforming the speed, quality and accuracy of data.
Delivering >90% compliance in real-world studies
By combining uMotif eCOA/ePRO with continuous glucose monitoring data capture, we delivered unprecedented data compliance rates for a pan-European diabetes study.
Reducing study timelines by 30%
In an immunology study, our patient-centered eCOA/ePRO solution helped the sponsor complete data capture requirements 6 months early.
High-quality endpoint data
In an FDA-required CNS study, we engaged participants to capture submission-ready ePRO through their own devices (BYOD).
Why are we unique? We’ve always designed for patients first.
At uMotif, we have a relentless focus on understanding the patient journey and what drives patient behavior.
This deep knowledge allows us to design software that best meets the needs of patients and delivers exceptionally high levels of engagement to study sponsors.
We power patient-centered research.
Delivering GCP compliant research at scale in over 30 countries
Available in any language, from Arabic to Japanese, French and Chinese
All therapy areas
Over 30 therapeutic areas
All study settings
Leading expertise spanning clinical, real-world and post-marketing
Our key tool is the uMotif app. The app enables people to track their symptoms and treatments – an essential path to coping and surviving. Research shows that patients who self-track and share their data have better outcomes.”